CompletedNot Applicable

Medication Adherence and Lipid Management in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention: Application of the Transitional Care Model

China108 participantsStarted 2022-07-11

Plain-language summary

Patients with coronary heart disease (CHD) require long-term medication and lifestyle modification following percutaneous coronary intervention (PCI). However, they often face challenges such as poor medication adherence and inadequate self-management. This study aims to evaluate the effects of the transitional care model (TCM) on CHD patients after PCI, regarding medication adherence, self-efficacy, and lipid levels.

Who can participate

Age range47 Years – 58 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients clinically diagnosed with CHD according to established diagnostic criteria * patients who met the World Health Organization (WHO) indications for PCI * complete clinical data available Exclusion Criteria: * Patients with cognitive impairment * Patients with incomplete follow-up data. * Patients with comorbid malignancy * Patients with severe hepatic * Patients with renal insufficiency

What they're measuring

Medication Adherence

Timeframe: Baseline (before discharge) and 3 months after discharge

Trial details

NCT IDNCT07346664

SponsorQing Wang

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05-09

View on ClinicalTrials.gov More Transitional Care Model trials